Results 211 to 220 of about 52,178 (281)

NanoDeNovo: De Novo Design of Anti-Poliovirus I Sabin Strain Nanobodies by Semi-Automated Computational Pipeline. [PDF]

Int J Mol Sci
Kotelnikov DD, Tatarinova KS, Zhdanov DD.   +2 more
europepmc   +1 more source

A novel bispecific antibody targeting TNF-α and IL-6 receptor as a potent immunotherapeutic agent for inflammation. [PDF]

Appl Microbiol Biotechnol
Heravi M, Damough S, Mafakher L, Talebkhan Y, Nematollahi L, Ghazizadeh L, Ajdari S.   +6 more
europepmc   +1 more source

Paratope mapping of tilvestamab, an anti-AXL function-blocking antibody, using high-throughput bacterial expression of secreted scFv-osmY fusion proteins. [PDF]

Biosci Rep
Christakou E, Kursula P, Micklem D.
europepmc   +1 more source

Preclinical evaluation of CAR-T cell immunotherapy with a fully human EpCAM-specific scFv against pancreatic cancer. [PDF]

Cancer Immunol Immunother
Fan YY, Liu YL, Liu XF, Jiang SQ, Yang H, Zhang HR, Wei P, Huang QR.   +7 more
europepmc   +1 more source

Reliable repurposing of antibody interactome inside the cell

O’Shea CM, Shahzad R, Aghasoleimani K, Newman S, Panmanee J, Schalkwyk LC, Brooke GN, Benson FE, Trimmer JS, Bosco DA, Fujisawa T, Ichijo H, Cashman NR, Engel S, Wright GSA.   +14 more
europepmc   +1 more source

Detection of extracellular amyloid beta aggregates by an Aducanumab-based synNotch receptor: an in vitro proof-of-concept study. [PDF]

J Transl Med
Bergo NJ, Lee S, Siebrand CJ, Mayeri Z, Andersen JK, Walton CC.   +5 more
europepmc   +1 more source

In vitro evidence of HER2-selective cytotoxicity by scFv(Herceptin)-PE-STXA immunotoxin in gastric cancer cells. [PDF]

Biochem Biophys Rep
Sedighian H, Abdi A, Goleij Z, Fasihi-Ramandi M, Fooladi AAI.   +4 more
europepmc   +1 more source

Fine-tuning affinity and spacer design enhances T cell potency in DLL3 and BCMA CAR T cells. [PDF]

MAbs
Mazzanti N, Tamot N, Francese A, Luo J, Borrok MJ, Rossillo J, Plummer J, Patwardhan GA, Sum CS, Ports M, Spiller KL, Sukumar M.   +11 more
europepmc   +1 more source

AAV-mediated peripheral scFv's administration to reduce cerebral tau in adult P301S transgenic mice: Mono-vs. combination therapy. [PDF]

Mol Ther Methods Clin Dev
Katel S, Cicalo J, Vasciaveo V, Vecchio LM, Carrion J, Mahadeo L, Huerta PT, Choksi JD, Aubert I, Marambaud P, Giliberto L, d'Abramo C.   +11 more
europepmc   +1 more source

Switchbody, an Antigen-Responsive Enzyme Switch Based on Antibody and Its Working Principle. [PDF]

Adv Sci (Weinh)
Yasuda T, Ueno Y, Taguchi M, Tochio N, Yagi H, Yazaki S, Arai R, Zhu B, Kigawa T, Ueda H, Kitaguchi T.   +10 more
europepmc   +1 more source